In at least one case report, a patient developed a malignant SMARCB1-deficient desmoplastic spindle cell sarcoma associated with pre-existing sporadic meningioangiomatosis in the absence of germline SMARCB1 or NF2 mutations. This evidence concerns the gene SMARCB1 and spindle cell sarcoma.